Lineage Cell Therapeutics
LCTX
#8126
Rank
A$0.48 B
Marketcap
A$1.95
Share price
3.85%
Change (1 day)
25.43%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -A$31.88 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are A$10.81 Million. In 2024 the company made an earning of -A$30.95 Million, an increase over its 2023 earnings that were of -A$35.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$31.88 Million3%
2024 -A$30.95 Million-13.16%
2023 -A$35.64 Million9.83%
2022 -A$32.45 Million-54.24%
2021 -A$70.91 Million86.07%
2020 -A$38.11 Million-31.97%
2019 -A$56.02 Million-5.42%
2018 -A$59.23 Million1.1%
2017 -A$58.58 Million-31.06%
2016 -A$84.97 Million-10.38%
2015 -A$94.81 Million29.69%
2014 -A$73.11 Million31.68%
2013 -A$55.52 Million
2011 -A$26.95 Million89.78%
2010 -A$14.2 Million206.06%
2009 -A$4.64 Million-0.58%
2008 -A$4.67 Million164.89%
2007 -A$1.77 Million-30.22%
2006 -A$2.53 Million
2002 -A$2.94 Million-41.04%
2001 -A$4.98 Million-32.04%
2000 -A$7.32 Million-11.85%
1999 -A$8.3 Million
1997 -A$5.34 Million12.12%
1996 -A$4.76 Million106.25%
1995 -A$2.31 Million-11.11%
1994 -A$2.6 Million50%
1993 -A$1.73 Million20%
1992 -A$1.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.21 Billion 603.03%๐Ÿ‡บ๐Ÿ‡ธ USA